Dr Anwar Alhaq, is the Genomics Programme Director at King’s College Hospital, London, and a board member of the South East Genomics Laboratory Hub/Genomics Medicine Service Alliance. He is the co-director of the AI/Cogstack programme at King’s and is currently one of the principal investigators in NHS England’s Networks of Excellence in AI.

Dr Alhaq is has been a peer reviewer for the United Kingdom & Belgium Accreditation Services for medical laboratory services and a past reviewer of the Healthcare Inspectorate Wales. As an academic researcher, he was a principal investigator and senior lecturer at KCL, London from 2002-2012 and a visiting senior lecturer at Kingston University, helping to set up and teach on the MSc programme on Cancer Studies.

Dr Alhaq is a Clinical Medical Advisor to the African Export-Import Bank (Afreximbank), leading the Bank’s strategy of developing a chain of African Medical Centres of Excellence (AMCE) focusing on delivering tertiary referral centres. He is a non-executive director of the first AMCE in Abuja, Nigeria, focusing on cancer, cardiovascular disease, and haematological medicine.

Dr Alhaq served as Chief Clinical Scientist at King’s College Hospital from 2016-2022 and was a non-executive director of Viapath Pathology from 2012-2018. At an operational role, he has held several divisional roles within KingsPath and Viapath pathology services and was an operational lead and board member of the South-East pathology Transformation Programme from 2018-2021. He was operational lead for the 100,000 Genomes project at King’s College Hospital from 2014-2018. During the COVID-19 pandemic, he was seconded to the NHS Test & Trace programme to help expand the SARS-CoV2 PCR testing capacity both locally and nationally, and to establish a robust framework for validating new SARS-CoV2 testing.